A subset of pituitary tumors present an aggressive behavior that remains difficult to predict, and in rare cases they metastasize. The current European Society for Endocrinology (ESE) guidelines for the management of aggressive pituitary tumors and carcinomas provide valuable guidance, but several issues remain unaddressed because of the scarcity of data in the literature. This article presents key clinical aspects regarding aggressive pituitary tumors and carcinomas, and also discusses some of the unanswered questions of the ESE guidelines, focusing on both diagnosis and treatment.
Keywords: Aggressive pituitary tumor; Definition; Diagnosis; Pituitary carcinoma; Stupp protocol; Temozolomide; Treatment; Tumor growth.
Copyright © 2020 Elsevier Inc. All rights reserved.